These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 37141858

  • 21. Temporal and tissue-specific variability of SMN protein levels in mouse models of spinal muscular atrophy.
    Groen EJN, Perenthaler E, Courtney NL, Jordan CY, Shorrock HK, van der Hoorn D, Huang YT, Murray LM, Viero G, Gillingwater TH.
    Hum Mol Genet; 2018 Aug 15; 27(16):2851-2862. PubMed ID: 29790918
    [Abstract] [Full Text] [Related]

  • 22. c.835-5T>G Variant in SMN1 Gene Causes Transcript Exclusion of Exon 7 and Spinal Muscular Atrophy.
    Wu S, Li YL, Cheng NY, Wang C, Dong EL, Lu YQ, Li JJ, Guo XX, Lin X, Lai LL, Liu ZW, Wang N, Chen WJ.
    J Mol Neurosci; 2018 Jun 15; 65(2):196-202. PubMed ID: 29799103
    [Abstract] [Full Text] [Related]

  • 23. Plastin 3 Expression Does Not Modify Spinal Muscular Atrophy Severity in the ∆7 SMA Mouse.
    McGovern VL, Massoni-Laporte A, Wang X, Le TT, Le HT, Beattie CE, Rich MM, Burghes AH.
    PLoS One; 2015 Jun 15; 10(7):e0132364. PubMed ID: 26134627
    [Abstract] [Full Text] [Related]

  • 24. Transgenic inactivation of murine myostatin does not decrease the severity of disease in a model of Spinal Muscular Atrophy.
    Rindt H, Buckley DM, Vale SM, Krogman M, Rose FF, Garcia ML, Lorson CL.
    Neuromuscul Disord; 2012 Mar 15; 22(3):277-85. PubMed ID: 22079083
    [Abstract] [Full Text] [Related]

  • 25. SMN in spinal muscular atrophy and snRNP biogenesis.
    Coady TH, Lorson CL.
    Wiley Interdiscip Rev RNA; 2011 Mar 15; 2(4):546-64. PubMed ID: 21957043
    [Abstract] [Full Text] [Related]

  • 26. Spinal muscular atrophy: development and implementation of potential treatments.
    Arnold WD, Burghes AH.
    Ann Neurol; 2013 Sep 15; 74(3):348-62. PubMed ID: 23939659
    [Abstract] [Full Text] [Related]

  • 27. [Alternative splicing and the cure of spinal muscular atrophy].
    Marasco LE, Stigliano J, Kornblihtt AR.
    Medicina (B Aires); 2019 Sep 15; 79(Spec 6/1):582-586. PubMed ID: 31864230
    [Abstract] [Full Text] [Related]

  • 28. Notch Signaling Mediates Astrocyte Abnormality in Spinal Muscular Atrophy Model Systems.
    Ohuchi K, Funato M, Yoshino Y, Ando S, Inagaki S, Sato A, Kawase C, Seki J, Saito T, Nishio H, Nakamura S, Shimazawa M, Kaneko H, Hara H.
    Sci Rep; 2019 Mar 06; 9(1):3701. PubMed ID: 30842449
    [Abstract] [Full Text] [Related]

  • 29. Trans-splicing-mediated improvement in a severe mouse model of spinal muscular atrophy.
    Coady TH, Lorson CL.
    J Neurosci; 2010 Jan 06; 30(1):126-30. PubMed ID: 20053895
    [Abstract] [Full Text] [Related]

  • 30. Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model.
    Hua Y, Sahashi K, Rigo F, Hung G, Horev G, Bennett CF, Krainer AR.
    Nature; 2011 Oct 05; 478(7367):123-6. PubMed ID: 21979052
    [Abstract] [Full Text] [Related]

  • 31. Genomic Variability in the Survival Motor Neuron Genes (SMN1 and SMN2): Implications for Spinal Muscular Atrophy Phenotype and Therapeutics Development.
    Butchbach MER.
    Int J Mol Sci; 2021 Jul 23; 22(15):. PubMed ID: 34360669
    [Abstract] [Full Text] [Related]

  • 32. Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?
    Burghes AH, Beattie CE.
    Nat Rev Neurosci; 2009 Aug 23; 10(8):597-609. PubMed ID: 19584893
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Dysregulation of ubiquitin homeostasis and β-catenin signaling promote spinal muscular atrophy.
    Wishart TM, Mutsaers CA, Riessland M, Reimer MM, Hunter G, Hannam ML, Eaton SL, Fuller HR, Roche SL, Somers E, Morse R, Young PJ, Lamont DJ, Hammerschmidt M, Joshi A, Hohenstein P, Morris GE, Parson SH, Skehel PA, Becker T, Robinson IM, Becker CG, Wirth B, Gillingwater TH.
    J Clin Invest; 2014 Apr 23; 124(4):1821-34. PubMed ID: 24590288
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. A SMN2 Splicing Modifier Rescues the Disease Phenotypes in an In Vitro Human Spinal Muscular Atrophy Model.
    Son YS, Choi K, Lee H, Kwon O, Jung KB, Cho S, Baek J, Son B, Kang SM, Kang M, Yoon J, Shen H, Lee S, Oh JH, Lee HA, Lee MO, Cho HS, Jung CR, Kim J, Cho S, Son MY.
    Stem Cells Dev; 2019 Apr 01; 28(7):438-453. PubMed ID: 30667343
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.